Trying to separate three different claims about phenylpiracetam: that it is the right molecule, that it is the right dose, and that it does something useful.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
I would rather have a narrow conclusion and be right than a broad one and be interesting.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Loose evidence is not the same as no evidence and people overcorrect in both directions.
Headache is the classic first-week effect and choline usually sorts it.
Anyone got a paper worth reading on this rather than a write-up of a paper?
Is a baseline blood test really necessary before starting something like this?
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation.
Cold storage, light protection, date on the vial. Boring, removes half the variables.
How long before you can reasonably say something is or is not doing anything?
Same here.
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid.
Nobody has ever been talked out of a stack by a stranger on the internet.
Narrow conclusion.